India Pharma 2026 highlights policy push, innovation driving sectoral growth EP News Bureau Apr 14, 2026 India is poised to lead the global pharma landscape with a focus on biosimilars and specialty medicines stressed J.P. Nadda, Union…
Glenmark Pharma and Menarini enter into exclusive licensing agreement for commercialising Ryaltris… EP News Bureau Dec 23, 2020 Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltris…
